London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
A
Arianna CerutiLeipzig University, Germany
Adela Alcolea-MedinaSynnovis, Guy’s and St Thomas’ NHS Foundation Trust, UK
Amy DentonWellcome Sanger Institute, UK
Adam GiessGenomics England, UK
Alfredo Hidalgo-MirandaNational Institute of Genomic Medicine, Mexico
Amanda HughesLonza, The Netherlands
Arnfinnur KallsbergFaroese Health Authority, Faroe Islands
Alberto MagiUniversity of Florence, Italy
Ailsa MacCalmanUniversity of Exeter, UK
Anna Maria NiewiadomskaAssociate Director, Segment Marketing — Micro & Infectious Disease, Oxford Nanopore Technologies
Alvin NgNanyang Technological University, Singapore
Alice OsmastonUniversity College London, UK
Ashley PritchardGreat Ormond Street Hospital for Children NHS Foundation Trust, UK
André ReisGarvan Institute of Medical Research, Australia
Anna RommerskirchenHeinrich-Heine University Dusseldorf, Germany
Alessandra RenieriUniversity of Siena, Italy
Art RandResearch Scientist, Machine Learning, Oxford Nanopore Technologies
C
Carla ApazaPeruvian University Cayetano Heredia, Peru
Chanatjit CheawsamootChulalongkorn University, Thailand
Christoph DieterichHeidelberg University, Germany
Cecilia ManciniBambino Gesù Children’s Hospital, Italy
Claudia StrafellaSanta Lucia Foundation IRCCS, Italy
Catriona WilliamsDevelopment Scientist — Sample Technology, Oxford Nanopore Technologies
E
Eilis HannonUniversity of Exeter, UK
Emma WhiteVP, Marketing, Oxford Nanopore Technologies
Eleanor WoodwardNewcastle University, UK
Eugenie ‘Charley’ YenUniversity of Massachusetts Amherst, USA & Queen Mary University of London, UK
F
Fritz SedlazeckBaylor College of Medicine, USA
Francis Van ParysChief Executive Officer, Oxford Nanopore Technologies
G
Gabrielle HartleyUniversity of Connecticut, USA
Graham HallVP, Sequencing Development, Oxford Nanopore Technologies
J
Javeria AijazIndus Hospital & Health Network, Pakistan
Jaime ChavesSan Francisco State University, USA
Jamie MooreJohns Hopkins University, USA
Jayne WallaceVP, Nanopore Research and Protein Sequencing, Oxford Nanopore Technologies
K
Kimberley BillingsleyNational Institutes of Health, USA
Kumeren GovenderUniversity of Oxford, UK
Kamil KhanipovThe University of Texas Medical Branch, USA
Kylie MontgomeryUK DRI at Cambridge, UK
L
Luke Blagdon SnellKing’s College London, UK
Lucas Esteban WangePompeu Fabra University, Spain
Lakmal JayasingheChief Scientific Officer, Oxford Nanopore Technologies
Lennart KesterPrincess Maxima Center for Pediatric Oncology, The Netherlands
Lara UrbanUniversity of Zurich, Switzerland
M
Mariana Bisarro dos ReisBarretos Cancer Hospital, Brazil
Max BloomfieldAwanui Laboratories Wellington, New Zealand
Mark BruceVP, Sequencing Methods Research, Oxford Nanopore Technologies
Mike ClarkThe University of Melbourne, Australia
Monika CechovaMasaryk University, Czechia
Mae DolendoSt. Jude Global Asia Pacific, Philippines
Mikhail KolmogorovNational Cancer Institute, USA
Madeline PageUniversity of Kentucky, USA
Min Seon ParkUniversity of Washington, USA
Mayur PariharTata Medical Center, India
Maria Reyes Capilla-GuerraDana-Farber Cancer Institute, USA
Marta RudziteBioinformatics Software Developer, Oxford Nanopore Technologies
Macey SlotaUniversity of California, San Francisco, USA
Mike VellaVP, Machine Learning, Oxford Nanopore Technologies
N
Natalia GarciaBioinformatics Software Developer, Oxford Nanopore Technologies
Ni-Chung LeeNational Taiwan University Hospital, Taiwan
R
Roland ArnoldUniversity of Birmingham, UK
Robert A. EdwardsFlinders University, Australia
Richard CristUniversity of Pennsylvania, USA
Rebecca DeaneAutomation Manager, Oxford Nanopore Technologies
Rowan HowellGenomics England, UK
Rebecca StubbsSenior Bioinformatician, Commercial Applications, Oxford Nanopore Technologies
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
Roy WilliamsAspen Neuroscience, USA
S
Sophie EhresmannUdeM & IRCM, Canada
Sandy FongSickKids Research Institute, Canada
Stefan Hardy LungInstitute of Virology Innsbruck, Austria
Sissel JuulVP, Applications, Oxford Nanopore Technologies
Sebastian LunkeVictorian Clinical Genetics Services, Australia
Sefi PrawerThe University of Melbourne, Australia
Steven VerbruggenOHMX.bio, Belgium
Oxford Nanopore Technologies
Sissel Juul
- Job title
- Institution
- VP, Applications, Oxford Nanopore Technologies
- Biography
Sissel Juul joined Oxford Nanopore more than a decade ago and leads its global, multidisciplinary Applications teams. They focus on translating the unique capabilities of Oxford Nanopore technology into impactful biological, clinical, and biopharma applications worldwide. The Applications team drives innovation by developing new solutions and analysis tools, running rigorous performance benchmarks, and working closely with customers to accelerate adoption and support success.
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
